Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

d3 Medicine

d3 Medicine?uq=AFYHfsyn
2012 FOUNDED
M&A STATUS
11-20 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of oncology drug development and research. The company focuses on developing medicines for infectious diseases, oncology and inflammation.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • 4 Century Drive
  • Parsippany-Troy Hills, NJ 07054
  • United States

+1 (973) 000-0000

d3 Medicine Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore d3 Medicine‘s full profile, request access.

Request full access to PitchBook

d3 Medicine Executive Team (5)

Name Title Board
Seat
Contact
Info
Craig Rayner Chief Executive Officer & Board Member
Leigh Farrell Ph.D Chief Operating Officer & Chairman
Regina Dutkowski Ph.D Chief Development Officer & Executive Director
Patrick Smith Chief Scientific Officer & Board Member
Vis Niranjan MD Chief Medical Officer

d3 Medicine Board Members (3)

Name Representing Role Since Contact
Info
00000 000000 d3 Medicine Chief Executive Officer & Board Member 000 0000
00000 0000000 00.0 d3 Medicine Chief Operating Officer & Chairman 000 0000
0000000 00000 d3 Medicine Chief Scientific Officer & Board Member 000 0000